Research

Macro partitioning

Rapid and significant weight loss induced by Tirzepatide leads to aesthetic changes, including facial volume loss ('Ozempic face'), skin laxity, and altered collagen structure, which are secondary to fat loss rather than direct drug toxicity.

Significant weight loss can cause your face to look older or saggy due to loss of facial fat. This is a side effect of the weight loss, not the drug itself. Eating enough protein and vitamins (like D and B12) during treatment may help maintain skin health.

ModerateSupportsMEDIUM confidence
Rapid or massive weight loss induced by agents like semaglutide and tirzepatide... is associated with a significant reduction in subcutaneous fat tissue volume, predisposing to tissue laxity... Facial lipoatrophy associated with GLP-1-induced weight loss (popularly termed 'Ozempic face') is described as the characteristic facial changes... These changes typically include facial volume and fat loss, skin sagging, hollowing of the cheeks and temples... These aesthetic changes are secondary to rapid weight loss and not a direct pharmacologic toxicity of the drug.
Heba Saed El‐Amawy · Anais Brasileiros de Dermatologia · 2025

Why this rating

Based on narrative review of case reports and mechanistic studies; causality is indirect (via weight loss).

Source

Tirzepatide in dermatology: cutaneous adverse events, emerging therapeutic roles, and cosmetic implications – A comprehensive review

Heba Saed El‐Amawy · Anais Brasileiros de Dermatologia · 2025

DOI 10.1016/j.abd.2025.501255

narrative_review
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →